425 related articles for article (PubMed ID: 12574225)
21. Absence of coupling between D2 dopamine receptors and calcium channels in lactotrophs from cycling female rats.
Rendt J; Oxford GS
Endocrinology; 1994 Aug; 135(2):501-8. PubMed ID: 8033799
[TBL] [Abstract][Full Text] [Related]
22. Dopamine inhibits prolactin secretion stimulated by the calcium channel agonist Bay-K-8644 through a pertussis toxin-sensitive G protein in anterior pituitary cells.
Enjalbert A; Musset F; Chénard C; Priam M; Kordon C; Heisler S
Endocrinology; 1988 Jul; 123(1):406-12. PubMed ID: 2454806
[TBL] [Abstract][Full Text] [Related]
23. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.
Akita S; Webster J; Ren SG; Takino H; Said J; Zand O; Melmed S
J Clin Invest; 1995 Mar; 95(3):1288-98. PubMed ID: 7883977
[TBL] [Abstract][Full Text] [Related]
24. Suppression of rat and human growth hormone and prolactin secretion by a novel somatostatin/dopaminergic chimeric ligand.
Ren SG; Kim S; Taylor J; Dong J; Moreau JP; Culler MD; Melmed S
J Clin Endocrinol Metab; 2003 Nov; 88(11):5414-21. PubMed ID: 14602782
[TBL] [Abstract][Full Text] [Related]
25. Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas.
Fusco A; Gunz G; Jaquet P; Dufour H; Germanetti AL; Culler MD; Barlier A; Saveanu A
Eur J Endocrinol; 2008 May; 158(5):595-603. PubMed ID: 18426817
[TBL] [Abstract][Full Text] [Related]
26. Leukaemia inhibitory factor and interleukin 6 inhibit secretion of prolactin and growth hormone by rat pituitary MtT/SM cells.
Tomida M; Yoshida U; Mogi C; Maruyama M; Goda H; Hatta Y; Inoue K
Cytokine; 2001 May; 14(4):202-7. PubMed ID: 11448119
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
[TBL] [Abstract][Full Text] [Related]
28. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice.
Asa SL; Kelly MA; Grandy DK; Low MJ
Endocrinology; 1999 Nov; 140(11):5348-55. PubMed ID: 10537166
[TBL] [Abstract][Full Text] [Related]
29. Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors.
Friedman E; Adams EF; Höög A; Gejman PV; Carson E; Larsson C; De Marco L; Werner S; Fahlbusch R; Nordenskjöld M
J Clin Endocrinol Metab; 1994 Mar; 78(3):568-74. PubMed ID: 7907340
[TBL] [Abstract][Full Text] [Related]
30. mPRs represent a novel target for PRL inhibition in experimental prolactinomas.
Camilletti MA; Abeledo-Machado A; Perez PA; Faraoni EY; De Fino F; Rulli SB; Ferraris J; Pisera D; Gutierrez S; Thomas P; Díaz-Torga G
Endocr Relat Cancer; 2019 May; 26(5):497-510. PubMed ID: 30856609
[TBL] [Abstract][Full Text] [Related]
31. Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas.
Zhang X; Danila DC; Katai M; Swearingen B; Klibanski A
J Clin Endocrinol Metab; 1999 Dec; 84(12):4652-5. PubMed ID: 10599733
[TBL] [Abstract][Full Text] [Related]
32. Pituitary prolactin-secreting tumor formation: recent developments.
Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of the inhibitory action of dopamine and somatostatin on prolactin secretion from human lactotrophs in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 Mar; 60(3):599-606. PubMed ID: 2579087
[TBL] [Abstract][Full Text] [Related]
34. Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression.
Pellegrini-Bouiller I; Morange-Ramos I; Barlier A; Gunz G; Figarella-Branger D; Cortet-Rudelli C; Grisoli F; Jaquet P; Enjalbert A
J Clin Endocrinol Metab; 1996 Sep; 81(9):3390-6. PubMed ID: 8784102
[TBL] [Abstract][Full Text] [Related]
35. Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo.
Bernard V; Lamothe S; Beau I; Guillou A; Martin A; Le Tissier P; Grattan D; Young J; Binart N
FASEB J; 2018 Sep; 32(9):4791-4797. PubMed ID: 29596024
[TBL] [Abstract][Full Text] [Related]
36. Pituitary PRL secretion induced by tetraethylammonium is inhibited by dopamine through D2 receptors.
Wang X; Sato N; Greer MA; Falardeau P
Mol Cell Endocrinol; 1995 Aug; 112(2):153-7. PubMed ID: 7489818
[TBL] [Abstract][Full Text] [Related]
37. Cell proliferation and death in the irradiated pituitary gland and its modification by growth stimulants.
Guo YP; Hendry JH; Morris ID; Davis JR; Beardwell CG
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):175-81. PubMed ID: 9212021
[TBL] [Abstract][Full Text] [Related]
38. Prolactin (PRL)-releasing peptide stimulates PRL secretion from human fetal pituitary cultures and growth hormone release from cultured pituitary adenomas.
Rubinek T; Hadani M; Barkai G; Melmed S; Shimon I
J Clin Endocrinol Metab; 2001 Jun; 86(6):2826-30. PubMed ID: 11397894
[TBL] [Abstract][Full Text] [Related]
39. Fetal Alcohol Exposure Reduces Dopamine Receptor D2 and Increases Pituitary Weight and Prolactin Production via Epigenetic Mechanisms.
Gangisetty O; Wynne O; Jabbar S; Nasello C; Sarkar DK
PLoS One; 2015; 10(10):e0140699. PubMed ID: 26509893
[TBL] [Abstract][Full Text] [Related]
40. Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development.
Kuchenbauer F; Theodoropoulou M; Hopfner U; Stalla J; Renner U; Tonn JC; Low MJ; Arzt E; Stalla GK; Páez-Pereda M
Mol Cell Endocrinol; 2003 Sep; 207(1-2):13-20. PubMed ID: 12972179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]